Skip to main content
Top
Published in: BMC Public Health 1/2024

Open Access 01-12-2024 | COVID-19 | Research

Correlation of pre-existing comorbidities with disease severity in individuals infected with SARS-COV-2 virus

Authors: Jasmina Marušić, Edhem Hasković, Adnan Mujezinović, Vedran Đido

Published in: BMC Public Health | Issue 1/2024

Login to get access

Summary

Shortly after the first publication on the new disease called Coronavirus Disease 2019 (Covid-19), studies on the causal consequences of this disease began to emerge, initially focusing only on transmission methods, and later on its consequences analyzed in terms of gender, age, and the presence of comorbidities. The aim of our research is to determine which comorbidities have the greatest negative impact on the worsening of the disease, namely which comorbidities indicate a predisposition to severe Covid-19, and to understand the gender and age representation of participants and comorbidities. The results of our study show that the dominant gender is male at 54.4% and the age of 65 and older. The most common comorbidities are arterial hypertension, diabetes mellitus, and cardiovascular diseases. The dominant group is recovered participants aged 65 and older, with comorbidities most frequently present in this group. The highest correlation between patients with different severity of the disease was found with cardiovascular diseases, while the coefficient is slightly lower for the relationship between patients with different disease severity and urinary system diseases and hypertension. According to the regression analysis results, we showed that urinary system diseases have the greatest negative impact on the worsening of Covid-19, with the tested coefficient b being statistically significant as it is 0.030 < 0.05. An increase in cardiovascular diseases affects the worsening of Covid-19, with the tested coefficient b being statistically significant as it is 0.030 < 0.05. When it comes to arterial hypertension, it has a small impact on the worsening of Covid-19, but its tested coefficient b is not statistically significant as it is 0.169 > 0.05. The same applies to diabetes mellitus, which also has a small impact on the worsening of Covid-19, but its tested coefficient b is not statistically significant as it is 0.336 > 0.05. Our study has shown that comorbidities such as urinary system diseases and cardiovascular diseases tend to have a negative impact on Covid-19, leading to a poor outcome resulting in death, while diabetes mellitus and hypertension have an impact but without statistical significance.
Literature
1.
2.
go back to reference Mouliou DS, Pantazopoulos I, Gourgoulianis KI. COVID-19 smart diagnosis in the Emergency Department: all-in in practice. Expert Rev Respir Med. 2022;16(3):263–72.CrossRefPubMed Mouliou DS, Pantazopoulos I, Gourgoulianis KI. COVID-19 smart diagnosis in the Emergency Department: all-in in practice. Expert Rev Respir Med. 2022;16(3):263–72.CrossRefPubMed
3.
go back to reference Mouliou DS, Gourgoulianis KI. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives. Expert Rev Respir Med. 2021;5(8):993–1002.CrossRef Mouliou DS, Gourgoulianis KI. False-positive and false-negative COVID-19 cases: respiratory prevention and management strategies, vaccination, and further perspectives. Expert Rev Respir Med. 2021;5(8):993–1002.CrossRef
5.
go back to reference Elemam NM, Hannawi H, Salmi IA, Naeem KB, Alokaily F, Hannawi S. Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates. Saudi Med J. 2021;42(2):170–80.CrossRefPubMedPubMedCentral Elemam NM, Hannawi H, Salmi IA, Naeem KB, Alokaily F, Hannawi S. Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates. Saudi Med J. 2021;42(2):170–80.CrossRefPubMedPubMedCentral
6.
go back to reference Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.CrossRefPubMed Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–20.CrossRefPubMed
7.
go back to reference Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G. COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res. 2020;158:104906.CrossRefPubMedPubMedCentral Tadic M, Cuspidi C, Mancia G, Dell’Oro R, Grassi G. COVID-19, hypertension and cardiovascular diseases: should we change the therapy? Pharmacol Res. 2020;158:104906.CrossRefPubMedPubMedCentral
8.
go back to reference Samardžić J. Covid-19 and antihypertensive therapy. Medicus. 2020;29(2):191–6. Samardžić J. Covid-19 and antihypertensive therapy. Medicus. 2020;29(2):191–6.
9.
go back to reference Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;1(7):811–8.CrossRef Guo T, Fan Y, Chen M, Wu X, Zhang L, He T, Wang H, Wan J, Wang X, Lu Z. Cardiovascular implications of fatal outcomes of patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020;1(7):811–8.CrossRef
10.
go back to reference Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, Jia H, Hu J, Gao J, Zhang Y, Zhang X, Yu G, Wang X, Gu J, Ye C, Jin C, Lu Y, Yu X, Yu X, Ren Y, Qiu Y, Li L, Sheng J, Yang Y. Analysis of epidemiological and clinical features in older patients with Coronavirus Disease 2019 (COVID-19) outside Wuhan. Clin Infect Dis. 2020;2871(15):740–7.CrossRef Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, Jia H, Hu J, Gao J, Zhang Y, Zhang X, Yu G, Wang X, Gu J, Ye C, Jin C, Lu Y, Yu X, Yu X, Ren Y, Qiu Y, Li L, Sheng J, Yang Y. Analysis of epidemiological and clinical features in older patients with Coronavirus Disease 2019 (COVID-19) outside Wuhan. Clin Infect Dis. 2020;2871(15):740–7.CrossRef
11.
go back to reference Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for Coronavirus Disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020;1(7):825–30.CrossRef Li J, Wang X, Chen J, Zhang H, Deng A. Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for Coronavirus Disease 2019 (COVID-19) infection in Wuhan, China. JAMA Cardiol. 2020;1(7):825–30.CrossRef
12.
13.
go back to reference Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, et al. Covid-19 and cardivasucular disease. Circulation. 2020;141:1648–55.CrossRefPubMed Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, et al. Covid-19 and cardivasucular disease. Circulation. 2020;141:1648–55.CrossRefPubMed
14.
go back to reference Ventura-Clapier R, Dworatzek E, Seeland U, Kararigas G, Arnal JF, Brunelleschi S, Carpenter TC, Erdmann J, Franconi F, Giannetta E, Glezerman M, Hofmann SM, Junien C, Katai M, Kublickiene K, König IR, Majdic G, Malorni W, Mieth C, Miller VM, Reynolds RM, Shimokawa H, Tannenbaum C. D’Ursi AM, Regitz-Zagrosek V. Sex in basic research: concepts in the cardiovascular field. Cardiovasc Res. 2017;1113(7):711–24.CrossRef Ventura-Clapier R, Dworatzek E, Seeland U, Kararigas G, Arnal JF, Brunelleschi S, Carpenter TC, Erdmann J, Franconi F, Giannetta E, Glezerman M, Hofmann SM, Junien C, Katai M, Kublickiene K, König IR, Majdic G, Malorni W, Mieth C, Miller VM, Reynolds RM, Shimokawa H, Tannenbaum C. D’Ursi AM, Regitz-Zagrosek V. Sex in basic research: concepts in the cardiovascular field. Cardiovasc Res. 2017;1113(7):711–24.CrossRef
15.
go back to reference Deng YY, Zheng Y, Cai GY, Chen XM, Hong Q. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-nCoV. Chin Med J (Engl). 2020;133:1129–31.CrossRefPubMed Deng YY, Zheng Y, Cai GY, Chen XM, Hong Q. Single-cell RNA sequencing data suggest a role for angiotensin-converting enzyme 2 in kidney impairment in patients infected with 2019-nCoV. Chin Med J (Engl). 2020;133:1129–31.CrossRefPubMed
16.
go back to reference Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14:182–95.CrossRef Zou X, Chen K, Zou J, Han P, Hao J, Han Z. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14:182–95.CrossRef
17.
go back to reference Hallak J, Teixeira TA, Bernardes FS, et al. SARS-CoV-2 and its relationship with the genitourinary tract: implications for male reproductive health in the context of COVID-19 pandemic. Andrology. 2021;9:73–9.CrossRefPubMed Hallak J, Teixeira TA, Bernardes FS, et al. SARS-CoV-2 and its relationship with the genitourinary tract: implications for male reproductive health in the context of COVID-19 pandemic. Andrology. 2021;9:73–9.CrossRefPubMed
18.
go back to reference Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, Agusti AA, Vogelmeier CF, Prevention of Chronic Obstructive Lung Disease. Global Initiative for the Diagnosis, Management, and. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1): 24–36. Halpin DMG, Criner GJ, Papi A, Singh D, Anzueto A, Martinez FJ, Agusti AA, Vogelmeier CF, Prevention of Chronic Obstructive Lung Disease. Global Initiative for the Diagnosis, Management, and. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2021;203(1): 24–36.
19.
go back to reference Higham A, Mathioudakis A, Vestbo J, Singh D. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29(158):200199.CrossRefPubMedPubMedCentral Higham A, Mathioudakis A, Vestbo J, Singh D. COVID-19 and COPD: a narrative review of the basic science and clinical outcomes. Eur Respir Rev. 2020;29(158):200199.CrossRefPubMedPubMedCentral
20.
go back to reference Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.CrossRefPubMed Daugherty SE, Guo Y, Heath K, et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.CrossRefPubMed
21.
go back to reference Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect. 2020;80(6):e14e8.CrossRef Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect. 2020;80(6):e14e8.CrossRef
22.
go back to reference Majdic G. Could Sex/Gender differences in ACE2 expression in the lungs contribute to the large gender disparity in the morbidity and mortality of patients infected with the SARS-CoV-2 Virus? Front Cell Infect Microbiol. 2020;9:10:327.CrossRef Majdic G. Could Sex/Gender differences in ACE2 expression in the lungs contribute to the large gender disparity in the morbidity and mortality of patients infected with the SARS-CoV-2 Virus? Front Cell Infect Microbiol. 2020;9:10:327.CrossRef
23.
go back to reference Castelli EC, de Castro MV, Naslavsky MS, Scliar MO, Silva NSB, Pereira RN, Ciriaco VAO, et al. MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. Front Immunol. 2022;2513:975918.CrossRef Castelli EC, de Castro MV, Naslavsky MS, Scliar MO, Silva NSB, Pereira RN, Ciriaco VAO, et al. MUC22, HLA-A, and HLA-DOB variants and COVID-19 in resilient super-agers from Brazil. Front Immunol. 2022;2513:975918.CrossRef
24.
go back to reference Guo W, Li M, Dong Y, U Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;31:e3319.CrossRef Guo W, Li M, Dong Y, U Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;31:e3319.CrossRef
25.
go back to reference Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, Health Care Workers, and Health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352–71.CrossRefPubMedPubMedCentral Driggin E, Madhavan MV, Bikdeli B, et al. Cardiovascular considerations for patients, Health Care Workers, and Health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020;75:2352–71.CrossRefPubMedPubMedCentral
26.
go back to reference Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020;29(10):9959–81.CrossRef Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging. 2020;29(10):9959–81.CrossRef
27.
go back to reference Puchongmart C, Boonmee P, Jirathanavichai S, Phanprasert N, Thirawattanasoot N, Dorongthom T, Monsomboon A, Praphruetkit N, Ruangsomboon O. Clinical factors associated with adverse clinical outcomes in elderly versus non-elderly COVID-19 emergency patients: a multi-center observational study. Int J Emerg Med. 2023;22(1):11.CrossRef Puchongmart C, Boonmee P, Jirathanavichai S, Phanprasert N, Thirawattanasoot N, Dorongthom T, Monsomboon A, Praphruetkit N, Ruangsomboon O. Clinical factors associated with adverse clinical outcomes in elderly versus non-elderly COVID-19 emergency patients: a multi-center observational study. Int J Emerg Med. 2023;22(1):11.CrossRef
28.
go back to reference Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;19(1):1742.CrossRef Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;19(1):1742.CrossRef
29.
go back to reference Chilazi M, Duffy EY, Thakkar A, et al. COVID and Cardicvascular Disease: what we know in 2021. CurrAtheroscler Rep. 2021;23:37. Chilazi M, Duffy EY, Thakkar A, et al. COVID and Cardicvascular Disease: what we know in 2021. CurrAtheroscler Rep. 2021;23:37.
30.
go back to reference Xu J, Xiao W, Liang X, Shi L, Zhang P, Wang Y, Wang Y, Yang H. A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity. BMC Public Health. 2021;11(1):1533.CrossRef Xu J, Xiao W, Liang X, Shi L, Zhang P, Wang Y, Wang Y, Yang H. A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity. BMC Public Health. 2021;11(1):1533.CrossRef
31.
go back to reference Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC Stateof-the-art review. J Am Coll Cardiol. 2020;75:2950–73.CrossRefPubMedPubMedCentral Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC Stateof-the-art review. J Am Coll Cardiol. 2020;75:2950–73.CrossRefPubMedPubMedCentral
32.
go back to reference Driggin E, Madhavan MV, Gupta A. The role of vitamin D in cardiovascular disease and COVID-19. Rev EndocrMetabDisord. 2020;23:293–7. Driggin E, Madhavan MV, Gupta A. The role of vitamin D in cardiovascular disease and COVID-19. Rev EndocrMetabDisord. 2020;23:293–7.
33.
go back to reference Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensiv. Care Med. 2020;46:1339–48.CrossRef Gabarre P, Dumas G, Dupont T, Darmon M, Azoulay E, Zafrani L. Acute kidney injury in critically ill patients with COVID-19. Intensiv. Care Med. 2020;46:1339–48.CrossRef
34.
go back to reference Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92:1902–14.CrossRefPubMedPubMedCentral Zhu J, Ji P, Pang J, Zhong Z, Li H, He C, Zhang J, Zhao C. Clinical characteristics of 3062 COVID-19 patients: a meta-analysis. J Med Virol. 2020;92:1902–14.CrossRefPubMedPubMedCentral
35.
go back to reference Benedetti C, Waldman M, Zaza G, Riella LV, Cravedi P. COVID-19 and the kidneys: an update. Front Med (Lausanne). 2020;21:7: 423.CrossRef Benedetti C, Waldman M, Zaza G, Riella LV, Cravedi P. COVID-19 and the kidneys: an update. Front Med (Lausanne). 2020;21:7: 423.CrossRef
36.
go back to reference Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590–2.CrossRefPubMed Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med. 2020;383(6):590–2.CrossRefPubMed
37.
go back to reference Chen A, Yin L, Lee K, He JC. Similarities and differences between COVID-19-Associated Nephropathy and HIV-Associated Nephropathy. Kidney Dis (Basel). 2021;29(1):1–12. Chen A, Yin L, Lee K, He JC. Similarities and differences between COVID-19-Associated Nephropathy and HIV-Associated Nephropathy. Kidney Dis (Basel). 2021;29(1):1–12.
38.
go back to reference Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S. Renin-angiotensin aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020;382:1653–9.CrossRefPubMed Vaduganathan M, Vardeny O, Michel T, McMurray J, Pfeffer M, Solomon S. Renin-angiotensin aldosterone system inhibitors in patients with COVID-19. N Engl J Med. 2020;382:1653–9.CrossRefPubMed
39.
go back to reference Singh J, Malik P, Patel N, et al. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clin Exp Med. 2022;22:125–35.CrossRefPubMed Singh J, Malik P, Patel N, et al. Kidney disease and COVID-19 disease severity-systematic review and meta-analysis. Clin Exp Med. 2022;22:125–35.CrossRefPubMed
40.
go back to reference Vahdat S. Clinical profile, outcome and management of kidney disease in COVID-19 patients - a narrative review. Eur Rev Med Pharmacol Sci. 2022;26(6):2188–95.PubMed Vahdat S. Clinical profile, outcome and management of kidney disease in COVID-19 patients - a narrative review. Eur Rev Med Pharmacol Sci. 2022;26(6):2188–95.PubMed
41.
go back to reference Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38.CrossRefPubMedPubMedCentral Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, Li J, Yao Y, Ge S, Xu G. Kidney disease is associated with in-hospital death of patients with COVID-19. Kidney Int. 2020;97(5):829–38.CrossRefPubMedPubMedCentral
42.
go back to reference Fabrizi F, Alfieri CM, Cerutti R, Lunghi G, Messa P. COVID-19 and acute kidney Injury: a systematic review and Meta-analysis. Pathogens. 2020;15(12):1052.CrossRef Fabrizi F, Alfieri CM, Cerutti R, Lunghi G, Messa P. COVID-19 and acute kidney Injury: a systematic review and Meta-analysis. Pathogens. 2020;15(12):1052.CrossRef
Metadata
Title
Correlation of pre-existing comorbidities with disease severity in individuals infected with SARS-COV-2 virus
Authors
Jasmina Marušić
Edhem Hasković
Adnan Mujezinović
Vedran Đido
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2024
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-024-18457-2

Other articles of this Issue 1/2024

BMC Public Health 1/2024 Go to the issue